Testing effectiveness (Phase 2)Study completedNCT02591095
What this trial is testing
ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer
Who this might be right for
Platinum-resistant or Refractory Ovarian Cancer
Centre Francois Baclesse 47